You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API extended phenytoin sodium


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing extended phenytoin sodium

Company Ingredient NDC Excipient
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 D&C YELLOW NO. 10
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 FD&C RED NO. 3
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 GELATIN
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 LACTOSE MONOHYDRATE
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 MAGNESIUM STEARATE
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 SUCROSE
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740 TALC
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for extended phenytoin sodium

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

extended phenytoin sodium drug variants containing GELATIN

Company Ingredient NDC
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740
Mylan Pharmaceuticals Inc extended phenytoin sodium 0378-2670
Wockhardt Limited extended phenytoin sodium 55648-720
Wockhardt USA LLC extended phenytoin sodium 64679-720
TYA Pharmaceuticals extended phenytoin sodium 64725-0720
Lupin Pharmaceuticals Inc extended phenytoin sodium 68180-561
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

extended phenytoin sodium drug variants containing MAGNESIUM STEARATE

Company Ingredient NDC
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740
Mylan Pharmaceuticals Inc extended phenytoin sodium 0378-2670
Wockhardt Limited extended phenytoin sodium 55648-720
Wockhardt USA LLC extended phenytoin sodium 64679-720
TYA Pharmaceuticals extended phenytoin sodium 64725-0720
Lupin Pharmaceuticals Inc extended phenytoin sodium 68180-561
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: SUCROSE

Excipient focus: SUCROSE STEARATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

extended phenytoin sodium drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
Parke-Davis Div of Pfizer Inc extended phenytoin sodium 0071-3740
Mylan Pharmaceuticals Inc extended phenytoin sodium 0378-2670
Wockhardt Limited extended phenytoin sodium 55648-720
Wockhardt USA LLC extended phenytoin sodium 64679-720
TYA Pharmaceuticals extended phenytoin sodium 64725-0720
Lupin Pharmaceuticals Inc extended phenytoin sodium 68180-561
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group